LMHC Substance Abuse and Addictions Counseling 3

Question 1

The term 'co-occurring disorders' in addiction counseling refers to a client who has:

Accepted Answer

Both a mental health disorder and a substance use disorder

Answer

Co-occurring disorders (also called dual diagnosis) refers to the simultaneous presence of a mental health disorder and a substance use disorder in the same individual.

Question 2

Which medications are FDA-approved for Medication-Assisted Treatment (MAT) of opioid use disorder?

Accepted Answer

Methadone and buprenorphine

Answer

Methadone and buprenorphine are both FDA-approved agonist/partial-agonist medications that reduce opioid cravings, withdrawal, and illicit drug use.

Question 3

A CAGE questionnaire score of 2 or more is clinically significant and indicates the need for:

Accepted Answer

Further clinical evaluation for alcohol use disorder

Answer

A CAGE score of 2 or more is a positive screen and warrants a comprehensive clinical assessment for alcohol use disorder before determining treatment level.

Question 4

When beginning counseling with a client suspected of having a substance use disorder, the LMHC's first priority should be to:

Accepted Answer

Conduct a comprehensive biopsychosocial assessment

Answer

A thorough biopsychosocial assessment establishes baseline functioning, diagnoses, severity, and informs individualized treatment planning before any intervention is selected.

Question 5

Contingency management in addiction treatment is best described as:

Accepted Answer

Using positive reinforcement such as vouchers to reward drug-negative urine samples

Answer

Contingency management is a behavioral intervention that uses tangible rewards (vouchers, prizes) to reinforce abstinence verified by negative drug tests.

(LMHC) Licensed Mental Health Counselor Certification Practice Test

(LMHC) Licensed Mental Health Counselor Certification Practice Test

LMHC Substance Abuse and Addictions Counseling 3